Could a pill keep bone sarcomas at bay? new study investigates
NCT ID NCT04055220
First seen Feb 18, 2026
Summary
This study is for people with bone sarcomas who have completed their first round of treatment. It tests whether taking regorafenib for up to 12 months can help prevent the cancer from coming back, compared to standard monitoring. About 168 participants will be randomly assigned to receive the drug or just be observed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
APHM - Hôpital Timone
RECRUITINGMarseille, 13385, France
Contact Email: •••••@•••••
-
APHP Hôpital Cochin
RECRUITINGParis, 75014, France
Contact Email: •••••@•••••
-
Centre Hospitalier Régional de Strasbourg Hautepierre
RECRUITINGStrasbourg, 67098, France
Contact Email: •••••@•••••
-
Centre Hospitalier Universitaire de Poitiers
NOT_YET_RECRUITINGPoitiers, 86000, France
Contact Email: •••••@•••••
-
Centre Hospitalier Universitaire de Saint-Etienne (CHUSE)
RECRUITINGSaint-Etienne, 42055, France
Contact Email: •••••@•••••
-
Centre Léon Bérard
RECRUITINGLyon, 69373, France
Contact Email: •••••@•••••
-
Centre Oscar Lambret
RECRUITINGLille, 59020, France
Contact Email: •••••@•••••
-
Centre Paul Strauss - Strasbourg
RECRUITINGStrasbourg, 67033, France
Contact Email: •••••@•••••
-
Hôpital Jean Minjoz
RECRUITINGBesançon, 25000, France
Contact Email: •••••@•••••
-
ICL Alexis Vautrin
NOT_YET_RECRUITINGVandœuvre-lès-Nancy, 54519, France
Contact Email: •••••@•••••
-
ICM Val d'Aurelle
NOT_YET_RECRUITINGMontpellier, 34298, France
Contact Email: •••••@•••••
-
ICO René Gauducheau
RECRUITINGSaint-Herblain, 44805, France
Contact Email: •••••@•••••
-
IUCT-Oncopole
NOT_YET_RECRUITINGToulouse, 31059, France
Contact Email: •••••@•••••
-
Institut Bergonié
RECRUITINGBordeaux, 33076, France
Contact Email: •••••@•••••
-
Institut Curie
RECRUITINGParis, 75005, France
Contact Email: •••••@•••••
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94805, France
Contact Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.